HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julian M Stewart Selected Research

Postural Orthostatic Tachycardia Syndrome

1/2021Supine Parasympathetic Withdrawal and Upright Sympathetic Activation Underly Abnormalities of the Baroreflex in Postural Tachycardia Syndrome: Effects of Pyridostigmine and Digoxin.
11/2019The Benefits of Oral Rehydration on Orthostatic Intolerance in Children with Postural Tachycardia Syndrome.
8/2014Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome.
2/2014A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
9/2011Ascorbate improves circulation in postural tachycardia syndrome.
9/2011Cutaneous constitutive nitric oxide synthase activation in postural tachycardia syndrome with splanchnic hyperemia.
5/2009Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.
1/2008Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.
12/2007Reduced body mass index is associated with increased angiotensin II in young women with postural tachycardia syndrome.
10/2007Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julian M Stewart Research Topics

Disease

13Postural Orthostatic Tachycardia Syndrome
01/2021 - 12/2002
6Orthostatic Intolerance
11/2019 - 12/2002
6Hyperemia
04/2017 - 12/2003
5Vasovagal Syncope
11/2017 - 12/2006
4Orthostatic Hypotension (Postural Hypotension)
01/2015 - 01/2008
4Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
11/2014 - 01/2007
3Hemorrhage
01/2019 - 03/2007
3Hypotension (Low Blood Pressure)
01/2016 - 05/2013
3Hypocapnia
12/2014 - 01/2007
2Syncope (Fainting)
12/2014 - 01/2008
2Dizziness (Lightheadedness)
11/2014 - 05/2013
2Tachycardia (Tachyarrhythmias)
02/2014 - 07/2008
2Hypoxia (Hypoxemia)
07/2011 - 04/2011
2Hypovolemia
01/2008 - 03/2007
1Weight Loss (Weight Reduction)
01/2018
1Chronic Kidney Failure (Chronic Renal Failure)
10/2017
1Hyperventilation
11/2014
1Mental Fatigue
12/2013
1Hypertension (High Blood Pressure)
06/2013
1Major Depressive Disorder (Major Depressive Disorders)
09/2012
1Anxiety Disorders (Anxiety Disorder)
09/2012
1Mitochondrial Diseases (Mitochondrial Disease)
09/2012
1Hypercapnia
04/2011
1Autonomic Nervous System Diseases (Dysautonomia)
01/2008

Drug/Important Bio-Agent (IBA)

7Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 10/2005
6Angiotensin IIIBA
09/2011 - 02/2006
4Nitric Oxide Synthase (NO Synthase)IBA
11/2017 - 07/2007
4Adrenergic Agents (Adrenergic Drugs)IBA
01/2016 - 12/2002
3Phenylephrine (Neo-Synephrine)FDA LinkGeneric
01/2016 - 04/2011
3SaltsIBA
01/2016 - 01/2008
3Oxygen (Dioxygen)IBA
12/2014 - 04/2011
3Midodrine (Midon)FDA LinkGeneric
02/2014 - 12/2006
2Arginine (L-Arginine)FDA Link
01/2016 - 07/2007
2hydroxide ionIBA
05/2013 - 01/2008
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
04/2011 - 07/2007
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
01/2021
1Digoxin (Digitek)FDA LinkGeneric
01/2021
1ORALIT (ORS)IBA
11/2019
1SolutionsIBA
11/2019
1omega-N-Methylarginine (NG Monomethyl L Arginine)IBA
01/2016
1DroxidopaIBA
01/2015
1Indomethacin (Indometacin)FDA LinkGeneric
12/2014
1Carbon DioxideIBA
12/2014
1Nitric Oxide DonorsIBA
08/2014
1TabletsIBA
12/2013
1VitaminsIBA
12/2013
1Oxyhemoglobins (Oxyhemoglobin)IBA
06/2013
1Hemoglobins (Hemoglobin)IBA
06/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013
1Lactic Acid (Lactate)FDA LinkGeneric
09/2012
1Phosphates (Orthophosphate)IBA
09/2012
1Glutathione (Reduced Glutathione)IBA
09/2012
1AntioxidantsIBA
09/2012
1angiotensin I (1-7)IBA
05/2009
1Angiotensin-Converting Enzyme 2IBA
05/2009
1IronIBA
07/2008
1Type 1 Angiotensin ReceptorIBA
01/2008
1Pharmaceutical PreparationsIBA
01/2008
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
07/2007
1KetorolacIBA
07/2007
1Biomarkers (Surrogate Marker)IBA
01/2007
1ReninIBA
02/2006
1AldosteroneIBA
02/2006
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
10/2005
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
12/2002
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
12/2002

Therapy/Procedure

5Lower Body Negative Pressure
11/2019 - 03/2007
2Therapeutics
11/2019 - 03/2007
2Bed Rest (Bedrest)
01/2018 - 10/2009
2Lasers (Laser)
07/2007 - 12/2003
1Fluid Therapy (Oral Rehydration Therapy)
11/2019
1Resuscitation
01/2019
1Renal Dialysis (Hemodialysis)
10/2017
1Injections
12/2013